IP Library Granted Patent US 11,084,867
Granted Patent B2
US 11,084,867 · App. 16/169,908 · Granted Aug 10, 2021

Regeneration of damaged tissue

Inventor: Anthony Steven Weiss (Sydney, AU)
Assignee: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
C07K14/78A61F13/00063A61F13/0213A61K9/0014A61K9/06A61K9/70A61K38/39A61L27/22A61L27/3633A61L27/56A61K38/00A61L2400/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,084,867
App. No.
16/169,908
Granted
Aug 10, 2021
Kind
B2
Abstract

A method of healing a wound including contacting a wound edge with a tropoelastin or elastin derived peptide in conditions for enabling a sustained contact of the tropoelastin with the wound edge for a time period for enabling re-epithelialization of the wound.

Claims (12)

1. A method of healing a wound including: providing an individual having a wound, the wound including a plurality of epidermal cells located about the wound thereby forming a wound edge; and

contacting the wound edge with a therapeutically effective amount of a composition comprising tropoelastin, the composition comprising a crosslinked hyaluronic acid gel and tropoelastin monomers that are not crosslinked, wherein the composition provides for a sustained release of the tropoelastin, and wherein the corn position is in contact with the wound edge for a time period to promote re-epithelialization of the wound.

2. The method of claim 1 , wherein the time period is no more than about 1 to 2 weeks.

3. The method of claim 1 , wherein the time period is about 1 to 3 weeks.

4. The method of claim 1 , wherein the composition comprises about 0.1 mg/mL to about 250 mg/mL of tropoelastin.

5. The method of claim 1 , wherein the re-epithelialization of the wound enables healing of the wound.

6. The method of claim 1 , wherein the wound is from an injury to skin tissue.

7. The method of claim 6 , wherein the injury causes breakage, rupture or wounding of an epidermal layer or a dermal layer.

8. The method of claim 1 , wherein the wound is a superficial wound, a partial thickness wound, or a full thickness wound.

9. The method of claim 1 , wherein the composition is provided in or on a solid phase.

10. The method of claim 9 , wherein the solid phase is a dressing, stent, scaffold, bulking agent, or prosthesis.

11. The method of claim 1 , wherein the wound is from surgery.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2021
From: WEISS, ANTHONY STEVEN
To: THE UNIVERSITY OF SYDNEY
Reel/Frame 056715/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2021
From: THE UNIVERSITY OF SYDNEY
To: ELASTAGEN PTY LTD
Reel/Frame 056715/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2021
From: ELASTAGEN PTY LTD
To: ALLERGAN AUSTRALIA PTY LTD
Reel/Frame 056715/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2021
From: ALLERGAN AUSTRALIA PTY LTD
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 056715/0364 →